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The incidence of portal vein thrombosis was ex· 
amined in 885 patients who received orthotopic liver 
transplantations for various end·stage liver diseases 
between 1989 and 1990. The thrombosis was classified 
into four grades. Grade 1 was thrombosis of intrahe· 
patic portal vein branches, grade 2 was thrombosis of 
the right or left portal branch or at the bifurcation, 
grade 3 was partial obstruction of the portal vein 
trunk, and grade 4 was complete obstruction of the 
portal vein trunk. Among the 849 patients without 
previous portosystemic shunt, 14 patients (1.6%) had 
grade 1, 27 patients (3.2%) had grade 2, 27 patients 
(3.2%) had grade 3 and 49 patients (5.8%) had grade 4 
portal vein thrombosis. The incidence of portal vein 
thrombosis was highest (34.8%) in the patients with 
hepatic malignancy in the cirrhotic liver, followed by 
those with Budd·Chiari syndrome (22.2%) and postne-
erotic cirrhosis of various causes (16.7%). The patients 
with encephalopathy, ascites, variceal bleeding, pre-
vious splenectomy and small liver had significantly 
higher incidences of portal vein thrombosis than the 
others. The total incidence of portal vein thrombosis 
among the 36 patients with previous portosystemic 
shunt was 38.9%, which was significantly higher than 
that (13.8%) of those without shunt. (HEPATOLOGY 
1992; 16; 1196-1198.) 
Thrombosis of the portal vein has been a formidable 
challenge to orthotopic liver transplantation (1-5). The 
incidence of portal vein thrombosis was examined in the 
orthotopic liver transplant recipients with various end-
stage liver diseases, and its relationship to several 
clinical features was studied. 
PATIENTS AND METHODS 
During the 2-yr period between January 1, 1989, and 
December 31, 1990,885 patients (522 males and 363 females) 
received the first orthotopic liver transplantation at the 
University Health Center of Pittsburgh. Their medical records 
Received September 17, 1991; accepted July 15, 1992. 
Supported by research grants from the Veterans Administration and Project 
Grant No. DK 29961 from the National Institutes of Health, Bethesda, 
Maryland. 
Address reprint requests to: Shunzaburo Iwatsuki, M.D., Falk Clinic 5C, 3601 
Fifth Avenue, Pittsburgh, PA 15213. 
31/1/41128 
were carefully reviewed. The ages ranged from 1 mo to 74 yr 
(mean ± S.D. = 41.2 ± 18.8 yr). 
The liver diseases of the patients are listed in Table 1. Portal 
vein thrombosis was determined by operative findings and 
pathological examinations of the excised livers at the time of 
liver transplantation. It was classified into the following four 
grades: (a) grade 1 = a partial (greater than 50% in diameter) 
or total thromboembolic and/or sclerotic obliteration of the 
intrahepatic (segmental) portal vein branches; (b) grade 2 = a 
partial (greater than 50% in diameter) or total thromboembolic 
and/or sclerotic obliteration of the right or left portal vein 
branch or near the bifurcation of the portal vein trunk in which 
a standard end-to-end portal vein anastomosis was feasible; (c) 
grade 3 = a partial (greater than 50% in diameter) thrombo-
embolic and/or sclerotic obliteration of the portal vein trunk in 
which an end-to-end portal vein anastomosis with or without 
a vein graft was feasible at the junction of the splenic and the 
superior mesenteric veins of the recipient; and (d) grade 4 = a 
complete or near complete (more than 90%) obliteration of the 
portal vein trunk in which an end-to-side portal-superior 
mesenteric vein anastomosis with a vein graft (a jump graft) or 
an end·to-end anastomosis at the junction of the splenic and 
superior mesenteric veins after thromboembolectomy of the 
veins was created with a vein graft (an interpositional graft). 
The incidence of portal vein thrombosis in various liver 
diseases and its relationship to liver weight and the history of 
ascites, encephalopathy, spontaneous bacterial peritonitis, 
gastrointestinal bleeding, endoscopic sclerotherapy for esoph-
ageal varices, splenectomy and porto systemic venous shunt 
were examined. Statistical comparisons between the groups 
were made using the X2 test and Student t test. The difference 
was considered significant when the p value was less than 0.05. 
RESULTS 
Incidence of Portal Vein Thrombosis in the Patients 
Without PortoBystemic Shunt. A total of 849 patients 
had not had the portosystemic shunt before transplan-
tation. A total of 117 (13.8%) of the 849 patients had 
some degree of portal vein thrombosis. A total of 49 
patients (5.8%) had complete obstruction (grade 4), and 
27 patients (3.2%) had partial obstruction (grade 3) of 
the portal vein trunk. Thus a total of 76 patients (9.0%) 
had surgically significant portal vein thrombosis for 
orthotopic liver transplantation. The remaining 41 
patients (4.8%) had portal vein thrombosis peripheral to 
the portal vein trunk (grade 1 and grade 2) (Table 1). 
High incidences of portal vein thrombosis were ob-
served in the patients with primary hepatic malignancy 
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TABLE 1. The incidence of portal vein thrombosis in various liver diseases without previous portosystemic shunt 
No. of No. (%) of patients with portal vein thrombosis 
Diagnosis patients Grade 1 Grade 2 Grade 3 Grade 4 Total 
Postnecrotic cirrhosis 401 8 (2.0%) 15 (3.7%) 16 (4.0%) 24 (6.0%) 63 (15.7%)G 
Alcoholic 149 6 (4.0%) 3 (2.0%) 7 (4.7%) 11 (7.4%) 27 (18.1%) 
Non-A, non-B 141 1 (0.7%) 5 (3.5%) 7 (5.0%) 8 (5.7%) 21 (14.9%) 
HBsAg positive 55 1 (1.8%) 5 (9.1%) 1 (1.8%) 2 (3.6%) 9 (16.4%) 
Autoimmune 21 0 1 (4.8%) 0 2 (9.5%) 3 (14.3%) 
Toxic (drug induced) 4 0 0 0 0 0 
Cryptogenic 21 0 1 (4.8%) 1 (4.8%) 1 (4.8%) 3 (14.3%) 
Others 10 0 0 0 0 0 
PBC 63 1 (1.5%) 3 (4.8%) 0 1 (1.6%) 5 (7.9%) 
Primary sclerosing cholangitis 56 0 0 1(1.8%) 1 (1.8%) 2 (3.6%) 
Inborn errors of metabolism (al - 40 0 0 0 2 (5.0%) 2 (5.0%) 
antitrypsin deficiency, Wilson's) 
Biliary atresia 84 0 1 (1.2%) 2 (2.4%) 1(1.2%) 4 (4.8%) 
Secondary biliary cirrhosis 32 1 (3.1%) 1 (3.1%) 0 3 (9.4%) 4 (12.5%) 
Budd-Chiari syndrome 9 0 0 0 2 (22.2%) 2 (22.2%) 
Hepatic malignancy with cirrhosis 87 4 (4.6%) 7 (8.0%) 8 (9.2%) 11 (12.6%) 30 (34.8%) 
Hepatic malignancy without cirrhosis 47 0 0 0 4 (8.5%) 4 (8.5%) 
Acute hepatic necrosis 25 0 0 0 0 0 
Others 5 0 0 0 0 0 
TOTAL 849 14 (1.6%) 27 (3.2%) 27 (3.2%) 49 (5.8%) 117 (13.8%) 
Grade 1 = thrombosis of intrahepatic portal vein branches; grade 2 = thrombosis of the first branches of portal vein or at the bifurcation; 
grade 3 ;: partial obstruction of the portal vein trunk; and grade 4 ;: complete obstruction of the portal vein trunk. 
"p < 0.05 VB. primary sclerosing cholangitis and p < 0.01 vs. biliary atresia. 
TABLE 2. Portal vein thrombosis in 36 patients with portosystemic shunt 
Type of No. of 
No. of patients with portal vein thrombosis 
portosystemic shunt patients Grade 1 Grade 2 Grade 3 Grade 4 Total Incidence 
PC shunt 13 N.A. N.A. N.A. 4 4 " N.A. 
Patent 9 N.A. N.A. N.A. 0 0 N.A. 
Occluded 4 N.A. N.A. N.A. 4 4 N.A. 
MC shunt 7 0 0 2 0 2 28.6% 
Patent 5 0 0 2 0 2 40.0% 
Occluded 2 0 0 0 0 0 0% 
PSRshunt 6 0 1 1 3 5 83.3% 
Patent 2 0 0 1 0 1 50.0% 
Occluded 4 0 1 0 3 4 100.0% 
DSR shunt 10 0 0 0 3 3 30.0% 
Patent 9 0 0 0 3 3 33.3% 
Occluded 1 0 0 0 0 0 0% 
TOTAL 36 0 1 3 9 14 38.9% 
PC = portacaval; MC ;: mesocaval; PSR = proximal splenorenal; DSR = distal splenorenal; and N.A. = not assessed. 
in the cirrhotic liver (34.8%), those with Budd-Chiari 
syndrome (22.2%) and those with postnecrotic cirrhosis 
(15.7%). Portal vein thrombosis in patients with PBC 
(7.9%), sclerosing cholangitis (3.6%), liver-based inborn 
errors of metabolism (5.0%) and biliary atresia (4.8%) 
were significantly less frequent than in those patients 
with postnecrotic cirrhosis (p < 0.05). The incidences of 
portal thrombosis were similar (14.3% to 18.1%) among 
various types of postnecrotic cirrhosis (Table 1). 
The portal vein thrombosis was actually caused by 
tumor emboli in 25 (83%) of the 30 cirrhotic patients 
with hepatic malignancy and in all of the four noncir-
rhotic patients with hepatic malignancy. 
Incidence of Portal Vein Thrombosis in Patients with 
Portosystemic Venous Shunt. A total of 36 patients 
had the portosystemic venous shunt before transplan-
tation. Twenty patients had postnecrotic cirrhosis, five 
had PBC, four had primary hepatic malignancy with 
associated cirrhosis and seven had other liver diseases. 
Because of the small number of cases, the incidences 
of portal vein thrombosis were examined on the basis 
of types of the shunt rather than types of liver 
diseases. 
Thirteen patients had portacaval shunts, 7 had me-
socaval shunts, 6 had proximal splenorenal shunts and 
10 had distal splenorenal shunts. Eleven of the 36 
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TABLE 3. Comparisons of liver weights (gmIkg) among four major liver diseases with or without portal vein thrombosis 
Liver weight (gm/kg, mean ± S.D.) 
Incidence of 
portal vein 
thrombosis (%) 
Total no. Patients with Patients without 
Diagnosis of patients portal vein thrombosis portal vein thrombosis 
Postnecrotic cirrhosis 20.6 ± 12.5G (n = 401) 17.2 ± 6.5b (n = 63) 21.1 ± 13.3 (n = 338) 15.7C 
7.9 
3.6 
4.8 
PBC 28.4 ± 12.1 (n = 63) 23.5 ± 5.0 (n = 5) 28.8 ± 12.5 (n = 58) 
Primary sclerosing cholangitis 27.9 ± 8.5 (n = 56) 21.3 ± 0.6 (n = 2) 28.1 ± 8.7 (n = 54) 
Biliary atresia 50.5 ± 20.5d (n = 84) 47.4 ± 18.4 (n = 4) 50.7 ± 20.5 (n = 80) 
"p < 0.0001 vs. PEC, primary sclerosing cholangitis, biliary atresia. 
bp < 0.02 VB. patients without portal vein thrombosis. 
cp < 0.02 vs. primary sclerosing cholangitis and p < 0.01 vs. biliary atresia. 
dp < 0.0001 vs. postnecrotic cirrhosis, PEC, primary sclerosing cholangitis. 
shunts were occluded (4 portacaval, 2 mesocaval, 4 
proximal splenorenal and 1 distal splenorenal). 
The incidences and the grades of portal vein throm-
bosis were stratified by the type of shunt as shown in 
Table 2. Ten (27.8%) of the 36 patients had complete 
obstruction (grade 4), and 3 patients (8.3%) had partial 
obstruction (grade 3) of the portal vein. 
Liver Weight and Portal Vein Thrombosis. The rela-
tionship between the liver weight and the portal vein 
thrombosis was examined among the patients with four 
of the most common liver diseases (postnecrotic cir-
rhosis, PBC, sclerosing cholangitis and biliary atresia) 
who had not had the portosystemic shunt (Table 3). The 
liver weights of patients with postnecrotic cirrhosis were 
significantly (p < 0.0001) lighter than those with PBC, 
sclerosing cholangitis and biliary atresia, and the inci-
dence of portal vein thrombosis of the former was 
significantly (p < 0.02) higher than those of the latter. 
In the postnecrotic cirrhosis, the liver weights of 
patients with portal vein thrombosis were significantly 
(p < 0.02) lighter than those without thrombosis. 
Clinical Features and Portal Vein Thrombosis. The 
relationship between the portal vein thrombosis and the 
clinical features (encephalopathy, ascites, spontaneous 
bacterial peritonitis, gastrointestinal bleeding, endo-
scopic sclerotherapy for esophageal varices and sple-
nectomy) was examined in the patients without porto-
systemic shunt (Table 4). The patients with chronic 
encephalopathy, refractory ascites, gastrointestinal 
bleeding or splenectomy had a significantly higher 
incidence of portal vein thrombosis than those without 
them. The endoscopic sclerotherapy and the sponta-
neous bacterial peritonitis could not be statistically 
related to the portal vein thrombosis. 
DISCUSSION 
The incidences of portal vein thrombosis in the 
literature range from 0.6% to 21 %, as shown in Table 5 
(6-13; Monarca, et al. Gastroenterology 1986;90:509, 
Correspondence). The reasons for this wide variation are 
mainly because of the differences in the methods of 
diagnosis, the liver diseases and the stages of cirrhosis. 
The lowest incidence of portal vein thrombosis in 
cirrhosis was 0.6% by Okuda et al. (12), in which the 
diagnosis was made by portography. In their report the 
TABLE 4. Incidence of portal vein thrombosis in various 
clinical conditions 
No. of No. of 
Condition patients thrombosis (%) pValue 
Encephalopathy 
Present 295 47 (15.9%) <0.02 
Absent 554 70 (12.6%) 
Ascites 
Present 538 82 (15.2%) <0.005 
Absent 311 35 (11.3%) 
Spontaneous bacterial peritonitis 
Present 77 16 (20.8%) NS 
Absent 772 101 (13.1%) 
Gastrointestinal bleeding 
Present 315 57 (18.1%) <0.001 
Absent 534 60 (11.2%) 
Sclerotherapy in gastrointestinal bleeders 
Present 181 36 (19.9%) NS 
Absent 134 21 (15.6%) 
Previous splenectomy 
Present 23 7 (30.4%) <0.01 
Absent 826 110 (13.3%) 
Patients with previous portosystemic shunt were excluded from the 
analysis. 
incidence of portal vein thrombosis among the patients 
with Child C cirrhosis was 1.3% and that of patients 
after splenectomy was 22.2%. The highest incidence of 
21 % was reported by Sarfeh (11). In this report all of the 
86 patients had had bleedings from es()phageal varices 
and underwent portal decompression surgery after 
portography. The degree of portal vein thrombosis 
reported in the literature (6-13; Monarca, et al. Gastro-
enterology 1986;90:509, Correspondence) appears to be 
mostly complete (grade 4) or partial (grade 3) ob-
struction. Including mural thrombosis, Chang and 
McFadzean (14) reported the incidence of 64.1% (41 of 
64) at autopsy. 
Complete obstruction of the portal vein was once 
considered as a contraindication for orthotopic liver 
transplantation (1). Recent technical advances (2-5) 
have made orthotopic liver transplantation possible even 
for the patient with complete portal vein thrombosis. In 
fact, those patients have not been excluded from 
orthotopic liver transplantation for the last several years 
-
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TABLE 5. Incidence of portal vein thrombosis in patients with cirrhosis 
Author 
(year of report) 
Hunt and Wittard (Reference 6) (1954) Unknown 
Operation 
Method of 
confirmation 
No. of Incidence 
patients (%) 
111 11.0 
104 10.6 Dye, David and Julian (Reference 7) (1960) 
Coomaraswamyet al. (Reference 8) (1964) 
Ranganathan and Burch (Reference 9) (1969) 
Sicot et al. (Reference 10) (1971) 
Operation or autopsy 
Autopsy 
63 11.1 
58 13.8 
Operation 250 5.2 
Sarieh (Reference 11) (1979) 
Okuda et al. (Reference 12) (1985) 
Angiography, splenoportography or operation 
Angiography or percutaneous transhepatic portog-
86 21.0 
708 0.6 
raphy 
Belli et al. (Reference 13) (1986) 
Monarca (Gastroenterology 1986;90:509; Corre-
spondence) (1986) 
Angiography or operation 
Autopsy 
512 16.6 
483 6.0 
Current study (1991) Operation and pathological examination 849" 13.8 
(9.0) 
Number in parentheses indicates incidence of grade 3 and grade 4 portal vein thrombosis. 
apatients with previous portosystemic shunt were excluded. 
if one of the major tributaries of the portal system has 
been suitable for venous allografting to supply the portal 
blood to the transplant liver. Thus the incidence of 
portal vein thrombosis reported in this study closely 
represents its actual incidence among the patients with 
end-stage liver disease who require liver replacement. 
We also note the high incidence (27.8%) of complete 
portal vein thrombosis among the patients with previous 
portosystemic shunt and the high incidence (85.3%) of 
tumor embolus as a cause of portal vein obstruction 
among the patients with hepatic malignancy. 
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